Ibn Sīnā
the man who wrote medicine's reference book.

Ibn Sīnā — Avicenna to the Latin West — was born around 980 near Bukhara, in what is now Uzbekistan. He was a prodigy of the kind that sounds invented: he had the Quran by heart at ten, worked through logic and mathematics as a boy, and came to medicine in his teens. He found it, he wrote, easy. He was treating patients at sixteen.

His break came when he cured the Samanid emir of Bukhara of an illness his court physicians could not. The reward he asked for was not money but access to the royal library — one of the great collections of the age. He read it through. Everything he wrote afterward grew from that room.

Avicenna's masterwork, al-Qānūn fī al-Ṭibb — the Canon of Medicine, finished around 1025 — set out to gather all of medicine into one ordered system. Five books, drawing together the Greek and Arab traditions and Avicenna's own judgement, arranged so that any question had a place to be looked up.

It worked. The Canon became the standard medical reference across the Islamic world and, in Latin translation, across Europe — taught at Montpellier and Padua into the seventeenth century. For roughly six hundred years, to look something up in medicine meant, somewhere, opening Avicenna.

The second of the Canon's five books is given over entirely to medicines: a systematic catalogue of some eight hundred simple drugs, each with its properties, its uses, and its cautions. It is the direct ancestor of the modern drug reference — the formulary, the database, the vocabulary of what a medicine is and does.

More striking still, Avicenna set down rules for deciding whether a drug actually works: the remedy must be pure, the case uncomplicated, the effect tested against contrary conditions and seen to repeat. It is a recognisably modern standard of evidence, written a thousand years early. Book Two is both a catalogue and a method.

Every prescription rests on a reference like Book Two: a shared, trusted account of each medicine — what it is, what it does, what it clashes with, how much is safe. The prescriber leans on it; so does the pharmacist who fills the script; so, increasingly, does the patient who wants to understand what they have been given.

The point of a reference is that everyone reads the same one. A drug database is Book Two's descendant: one canonical record per medicine, interactions and doses and warnings included, sitting quietly beneath every prescription as the safety net that catches what a busy clinician might not.

We gave the medicine reference Avicenna's name because that is what he built: the authoritative, shared account of medicines that a whole profession could stand on. Not a prescriber's private note — the common source of truth for whoever writes and whoever fills.

The Canon held that authority for six centuries because it was comprehensive, ordered, and honest about what it knew. That is still the whole job of a medicine database — and Book Two is still, in effect, open on the desk.